Clinical Trials Directory

Trials / Completed

CompletedNCT04733612

The Effects of Short Message Notifications on Middle-Aged Diabetic Patients

Effects of Short-Message Notifications on Medication Adherence, Physical Activity and Fasting Blood Glucose Control and Correlation of These With the Health-Related Quality of Life in Mid-aged Diabetic Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing information on diabetes via short message (SMS) technology.

Detailed description

The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral antidiabetic therapy for at least 1 The study design is a single-blinded randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul University Medical Faculty Hospital. Patients randomly assigned to the intervention group, in addition to traditional treatment received three to four informative SMS messages per week during the 6-month period, while the control group was followed in accordance with the traditional treatment schedule.

Conditions

Interventions

TypeNameDescription
OTHERInformative messagesIn addition to their standard treatments, an informative SMS (text message) on diabetes was sent to the intervention group three to four times a week for six months. The short messages were in the form of a short sentence for the subject and the predicate. The messages sent have been prepared in such a way that they do not exceed 1 SMS quota and are less than 160 characters on mobile phones.

Timeline

Start date
2016-06-30
Primary completion
2017-12-20
Completion
2018-02-26
First posted
2021-02-02
Last updated
2021-02-02

Source: ClinicalTrials.gov record NCT04733612. Inclusion in this directory is not an endorsement.